Surgical Treatment of Pancreatic Cancer

被引:92
作者
Loos, Martin [2 ]
Kleeff, Joerg [2 ]
Friess, Helmut [2 ]
Buechler, Markus W. [1 ]
机构
[1] Heidelberg Univ, Dept Gen Surg, D-69120 Heidelberg, Germany
[2] Tech Univ Munich, Dept Surg, Munich, Germany
来源
RECENT ADVANCES IN CLINICAL ONCOLOGY | 2008年 / 1138卷
关键词
pancreas; cancer; pancreatectomy;
D O I
10.1196/annals.1414.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pancreatic cancer is an aggressive disease with an overall 5-year survival rate of less than 5%. Up to date, surgical resection represents the basis of treatment for localized pancreatic cancer and remains the only chance for cure. Due to continuous improvements in surgical techniques and perioperative care, pancreatic resections have evolved into safe surgical procedures with low mortality and acceptable morbidity rates for experienced surgeons in high-volume centers. Recently, more aggressive approaches including extended lymphadenectomy, vascular resection, surgery for metastastic or recurrent disease, and multimodal regimens have been suggested to improve long-term outcome. This article provides an overview on current standard procedures and summarizes new strategies in the surgical treatment of pancreatic cancer.
引用
收藏
页码:169 / 180
页数:12
相关论文
共 50 条
[41]   Surgical Treatment of Pancreatic Metastases of Renal Cell Carcinoma [J].
Sotiropoulos, Georgios C. ;
Lang, Hauke ;
Liu, Chao ;
Brokalaki, Eirini I. ;
Molmenti, Ernesto ;
Broelsch, Christoph E. .
JOURNAL OF THE PANCREAS, 2005, 6 (04) :339-343
[42]   Surgical treatment of pancreatic metastases from renal carcinoma [J].
Peschaud, F ;
Cheynel, N ;
Hagry, O ;
Tremeaux, JC ;
Rat, P ;
Favre, JP .
ANNALES DE CHIRURGIE, 2002, 127 (07) :527-531
[43]   SURGICAL METHODS OF TREATMENT OF PATIENTS WITH FORMED PANCREATIC CYSTS [J].
Merzlikin, N. V. ;
Sled, N. Yu. ;
Popov, A. Ye. ;
Tskhaj, V. F. ;
Brazhnikova, N. A. ;
Shelepov, S. V. ;
Podgornov, V. F. ;
Gyunter, V. E. ;
Kapustinsky, A. N. ;
Bushlanov, P. S. .
BYULLETEN SIBIRSKOY MEDITSINY, 2015, 14 (02) :12-+
[44]   Surgical treatment of benign and borderline neoplasms of the pancreatic body [J].
Balzano, G ;
Zerbi, A ;
Veronesi, P ;
Cristallo, M ;
Di Carlo, V .
DIGESTIVE SURGERY, 2003, 20 (06) :506-510
[45]   Surgical resection strategies for locally advanced pancreatic cancer [J].
Gluth, Alexander ;
Werner, Jens ;
Hartwig, Werner .
LANGENBECKS ARCHIVES OF SURGERY, 2015, 400 (07) :757-765
[46]   Surgical resection strategies for locally advanced pancreatic cancer [J].
Alexander Gluth ;
Jens Werner ;
Werner Hartwig .
Langenbeck's Archives of Surgery, 2015, 400 :757-765
[47]   Immuno-Surgical Management of Pancreatic Cancer with Analysis of Cancer Exosomes [J].
Takeda, Yu ;
Kobayashi, Shogo ;
Kitakaze, Masatoshi ;
Yamada, Daisaku ;
Akita, Hirofumi ;
Asai, Ayumu ;
Konno, Masamitsu ;
Arai, Takahiro ;
Kitagawa, Toru ;
Ofusa, Ken ;
Yabumoto, Masami ;
Hirotsu, Takaaki ;
Vecchione, Andrea ;
Taniguchi, Masateru ;
Doki, Yuichiro ;
Eguchi, Hidetoshi ;
Ishii, Hideshi .
CELLS, 2020, 9 (07)
[48]   Adjuvant treatment strategies for pancreatic cancer [J].
Newman, Erika A. ;
Simeone, Diane M. ;
Mulholland, Michael W. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2006, 10 (06) :916-926
[49]   Treatment of Borderline Resectable Pancreatic Cancer [J].
Amanda B. Cooper ;
Ching-Wei D. Tzeng ;
Matthew H. G. Katz .
Current Treatment Options in Oncology, 2013, 14 :293-310
[50]   Erlotinib in the treatment of advanced pancreatic cancer [J].
Kelley, Robin K. ;
Ko, Andrew H. .
BIOLOGICS-TARGETS & THERAPY, 2008, 2 (01) :83-95